AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Sep 8, 2021
33298_dirs_2021-09-08_ae4e4780-2b3e-4819-977e-5983c9f75caf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-09-07
Reporting Person: Strawn John R Jr (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-07 | Restricted Stock Unit | $ | A | 10000 | Acquired | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 263347 | Direct |
| Common Stock | 60000 | Indirect |
Footnotes
F1: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly with 25% vesting on September 30, 2021, December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17